{"name":"Elpiscience Biopharma, Ltd.","slug":"elpiscience-biopharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ES102","genericName":"ES102","slug":"es102","indication":"Other","status":"phase_2"},{"name":"Part 1 ES002023","genericName":"Part 1 ES002023","slug":"part-1-es002023","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ES102","genericName":"ES102","slug":"es102","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Part 1 ES002023","genericName":"Part 1 ES002023","slug":"part-1-es002023","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWDlHaEVLaGZST3BHZU9CQjdnSVc1SjdaR1NsdGtldFZ2R3hFTVNBdHJVZzBuRzZ5ZzhHQk9HcXk3WjcyNVBRd3Znczc1TWNmQnNiUHdSRk5TQktaZ1h4TkdyQjZPcl9ueXZUWFZERHdzdUI2MkVnX1NLNmFkU19zMmtJMHJYUnRwNGdjNlRzZHk4eXp6eDVnQjZWcV9oRFE3a0ZhZjN2OFhLV2dUXzhwZ0hB?oc=5","date":"2024-12-02","type":"pipeline","source":"Bloomberg.com","summary":"Big Pharma’s Bet on China Biotech Is a Rare Trade Bright Spot - Bloomberg.com","headline":"Big Pharma’s Bet on China Biotech Is a Rare Trade Bright Spot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNZ2JlRGstal9kdW03RnhOZ18xNi03V3I2ZjU2UTFjN3VuOThFcUgybDd4c09vNnJWS1U2SnBqdzFYOG9qVGRPcU5XQ2E4LUV4WHV3LVA4UWd5RWIxN2R6clhTYklNV0RWUFNpbWVWM0E4cjFLVjE2dVFwWnJXaHBqeDM4aC03bEF3Y3Y1NXEzN2pEbTBEZTcwNmZKWS1BODh3MGdXcExfdkw1R2dUVmozd29sTnI?oc=5","date":"2024-07-03","type":"deal","source":"World Business Outlook","summary":"Elpiscience and Astellas enter into research collaboration and license agreement - World Business Outlook","headline":"Elpiscience and Astellas enter into research collaboration and license agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOWGRTVm80Q2pxcm95VmlzSWRzRG4yUkdvbDBfeW9zUnpGaTF5bDBJSGQ0NzJvRjRTWFVfZ05VckptVnlNT3lWVGN1T2ktelZOM3ktd0lYY01JWFplRnozbHc5QlZJZUthODVVVGVzRExrYTQwV0hTWXR0blJNd2phZU9TSzBkU01fbHc5dDhCUkE4REkxWjItMkpaYXpZLW1RN19WcU9ZYw?oc=5","date":"2024-05-16","type":"deal","source":"BioWorld News","summary":"J&J buys bispecific antibody developer Proteologix for $850M - BioWorld News","headline":"J&J buys bispecific antibody developer Proteologix for $850M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNTzJiQ2hUa1FrYjFTQWp0ckMzRXJaRWZ1SUVKUVRQMmJZZHFnRmpiaGctaXpZald2eHFkbTlSeUV0TmhrcEY2bXVscE1SQXlINEZyX0lqa0ZqMTEwNy1uaWtwSEF6dE9EQ2hCUUJweFhLOHp0TGQ2cUFXZ1ZTR1ZUR3dGclVnQVlsTWlJSG1tQTdZXzFIVmFRYlF4Nm1tdVJHY2NUOENzM010QTdIS25BTlBwZFVQUHNUZFlnRzJYOVJ3bjhPTHc?oc=5","date":"2024-05-08","type":"pipeline","source":"Clarivate","summary":"Pharma is placing bigger bets on fewer, more strategic assets and platforms - Clarivate","headline":"Pharma is placing bigger bets on fewer, more strategic assets and platforms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUnVPNmJQcU1yUGRtYWNNSjJPV29Zc0trd3lBZDhMckpJSWh3TWNNTHE1WG1pUjRMSGlDc2ZVU0Mwb256aHVhWGloMjJJanZkNnYxMWhNeTA5UzFUY0dVb3MyMnZpWlRDWW9KblFwdU5uQlAzRXY0MzY3NV9yNkVjTzk5VldSSUFqR0lvNlVLZ2RCSW5LLXpCaXFUZENqVmMzRHZBU2xUMDY?oc=5","date":"2024-03-27","type":"regulatory","source":"BioWorld News","summary":"Astellas wins first approval of Vyloy in gastric cancer in Japan - BioWorld News","headline":"Astellas wins first approval of Vyloy in gastric cancer in Japan","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQRmNCT3RSOFc2ZGVjb3NpTWo4QVpHMmhBTm52VWFlMTZDRlc3NFFlc1RiUDZlWnlIYnliTk54c1BkWEo0c1RDUUdxVG1ma2NZd0ZPM1hrZEc5ejV4UUtEaHVIc1RvX28tQVllVU9kNl83UzZVV21oYXdSMmw4T21uakhuRVkzbENEejRJbVE0TVY4a3d2UGpRaXhkY2pzTHJKbUJCOVV2MTJFQXlVVFdpaHRWaWF4TFlPQWs0Nmx2OU4yYmtDSVR6VDFMdjROLWx1YWF0eGtyelhFRWNUMmJqR3Z4VHZOejA3dlhxS09uVWU1eHhzTkNlOEtoSDJSQU5sWWIwMVJFUQ?oc=5","date":"2023-12-28","type":"deal","source":"prnewswire.com","summary":"Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager - prnewswire.com","headline":"Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOeHFyMVFCc2kyaW9mVUV1dEdLemEtaGk1NjNRV094S1NEdDh6YnFlWGs3MXZPS1JlUF9qWVJpd2N3VzVJSzE5QlhHMV9MSC1fX0k3SWRhLUlSU1B1V3Y2bTVqTk1vbFVLMF95UzhZbXIyOUMyYjhpYzZPSzRmUHVoNU9PRkZKNUUya1BXYmFueF9JMm90eHRVZUtn?oc=5","date":"2015-12-18","type":"pipeline","source":"Pharmafile","summary":"Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint - Pharmafile","headline":"Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}